compulsory licence

The U.S. Trade Representative's decision to place India on its annual trade "Watch List" is a bully tactic being used to punish the country for taking steps to ensure access to affordable,...

Statements, Speeches, Letters – Last updated 02 May 2013
msfaccess.org/content/us-penalises-india-promoting-access-medicines-strategies-placing-it-trade-watch-list

A liver cancer treatment is off-limits in the NHS due to its unjustifiably high price tag, but in India the same treatment is available for less than £100 a month. In this week's Scrubbing...

Op-eds & Articles – Last updated 28 March 2013
msfaccess.org/content/bbc-do-drugs-really-have-be-so-expensive

New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...

Statements, Speeches, Letters – Last updated 04 March 2013
msfaccess.org/content/india-upholds-compulsory-licence-cancer-drug-bayer-case-appeal

Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...

Statements, Speeches, Letters – Last updated 18 January 2013
msfaccess.org/content/final-hearings-begin-bayers-appeal-against-indian-move-allow-production-more-affordable

On 3 September, the Government of Indonesia issued a 'government use' decree - a type of compulsory licence that lifts a patent restriction on generic production - on seven drugs used to treat...

Statements, Speeches, Letters – Last updated 12 October 2012
msfaccess.org/content/msf-responds-indonesias-intent-issue-compulsory-licences-7-hiv-drugs

Thanks Mr. Chairman. I am speaking on behalf of Médecins Sans Frontières International. MSF is an independent medical humanitarian organisation that works in over 65 countries around...

Statements, Speeches, Letters – Last updated 06 October 2012
msfaccess.org/content/msf-statement-wipo-general-assemblies-agenda-item-28i-standing-committee-law-patents

17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...

Statements, Speeches, Letters – Last updated 17 September 2012
msfaccess.org/content/msf-statement-indias-dismissal-bayers-request-stay-compulsory-licence

German company appeals against life-saving compulsory licence decision in India Geneva/New Delhi, 3 September, 2012 – German pharmaceutical company Bayer today heads to India’s Intellectual...

Press Release – Last updated 26 September 2012
msfaccess.org/about-us/media-room/press-releases/bayer-attempts-block-affordable-patented-drugs-india

Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...

Statements, Speeches, Letters – Last updated 21 August 2012
msfaccess.org/content/bayernatco-compulsory-licence-appeal-%E2%80%93-hearings-postponed

Washington, DC, 25 July 2012 —Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released today from...

Press Release – Last updated 26 July 2012
msfaccess.org/about-us/media-room/press-releases/middle-income-countries-flex-muscles-overcome-patents-face